FDA creates new regulatory category for supplement NAC, resolving legal grey area
Published 1 d ago1 sourceEvidence: Reported
The FDA has proposed a rule to reverse its prior stance and allow N-acetyl-L-cysteine (NAC) to be marketed as a dietary supplement, provided products comply with other FD&C Act requirements. This follows years of regulatory ambiguity and enforcement discretion. If finalized, it would expand the legal supplement market for NAC, which is used in wellness products.
AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works
Published 1 d ago1 sourceEvidence: Reported
Published 12 h ago1 sourceEvidence: Reported
Published 5 h ago1 sourceEvidence: Reported
Published 2 d ago2 sourcesEvidence: Reported
Published 2 d ago2 sourcesEvidence: Reported
Published 1 d ago2 sourcesEvidence: Reported
Published 22 h ago3 sourcesEvidence: Reported
Published 1 d ago2 sourcesEvidence: Reported